Medical In-Patient Rehabilitation in Rheumatoid Arthritis

October 26, 2007 updated by: University of Luebeck

Medical In-Patient Rehabilitation in Rheumatoid Arthritis: Acceptance and Outcomes in Insurants of Compulsory Health Insurances and Statutory Pension Insurances (VERA)

The randomised controlled trial explores the efficacy of a counselling interview on an multidisciplinary multimodal intervention to ameliorate the somatic, mental and social medical progress of rheumatoid arthritis in gainfully employed insurants of compulsory health insurances and statutory pension insurances . Additionally, the feasibility to recruit a study population via databases of compulsory health insurances is examined.

Study Overview

Detailed Description

Rheumatoid arthritis is the most prevalent inflammatory rheumatic disease. Limited participation of the individual patient accumulates with large amounts of indirect costs for society: About 40 % of the affected patients have to quit their jobs within the first three to four years after disease onset. Nevertheless, the German health care system still seems to lack an adequate supply, particularly in case of medical rehabilitation in early stages of disease. International clinical trials, reviews amd evidence-based guidelines emphasize the importance of an early multimodal multidisciplinary team care as in Germany provided by specialised clinics through three-week in-patient medical rehabilitation programs. The available study explores the efficacy of a counselling interview on an medical in-patient rehabilitation in a randomised controlled design. Exclusively, gainfully employed insurants of compulsory health insurances and statutory pension insurances are included in the study.

Secondary, to avoid the problem of a selection bias caused by recruitment via clinics or doctors, the RCT tests the possibility to recruit potential participants by data of the co-operating health insurances on RA-specific diagnoses of work incapacity, hospital discharge diagnoses, and medical prescriptions within the past 24 months.

Detailed process:

  1. Recruitment of a potential study population via health insurance data (defined search criteria: ICD-10 diagnoses M05/06/13/79 in case of work disability/hospital discharge, RA-specific medical prescriptions within the past 24 months)
  2. screening questionnaire to verify in-/exclusion criteria
  3. selection of eligible insurants (RA-criteria of American College of Rheumatology, clinical expert)
  4. baseline measurement (e.g. SF-36, RAQoL, FFbH-P, SPE)
  5. external stratified block by block randomization: intervention group (3- week medical in-patient rehabilitation) vs. control group (usual care)
  6. follow-up measurement (12 months after baseline)
  7. data transfer of health insurances and pension insurances

Comparison:

Looking at a 12-months follow-up, the intervention group (3-week medical in-patient rehabilitation) is expected to show significant enhancement in somatic, mental and social medical parameters concerning rheumatoid arthritis compared to a control group receiving usual care.

Study Type

Interventional

Enrollment (Actual)

129

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Luebeck, Germany, 23538
        • Institute for Social Medicine, University of Luebeck

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 62 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Rheumatoid arthritis / psoriatic arthritis (expert decision, ACR criteria)
  • Insurant of co-operating health insurance and pension insurance
  • Gainfully employed
  • Eligible to receive a medical in-patient rehabilitation

Exclusion Criteria:

  • Polyarthritis, inflammatory intestinal diseases and diseases of connective tissue
  • Currently work disabled
  • Not able / not willing to co-operate
  • Medical in-patient rehabilitation within past 48 months

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: IG
intervention group, receives counselling on medical inpatient rehabilitation by statutory health insurance, is intended to apply for a 3-wek medical inpatient rehabilitation at the co-operating clinic (Bad Bramstedt)
Counselling and 3-week medical in-patient rehabilitation in IG
No Intervention: KG
control group, receives usual care

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
work incapacity (incidence, duration)
Time Frame: baseline, 12 months follow-up
baseline, 12 months follow-up

Secondary Outcome Measures

Outcome Measure
Time Frame
general health status (SF-36)
Time Frame: baseline, 12 months follow-up
baseline, 12 months follow-up
Functional capacity (FFbH-P)
Time Frame: baseline, 12 months follow-up
baseline, 12 months follow-up
Quality of life (RAQoL)
Time Frame: baseline
baseline
Subjective prognosis of gainful employment (SPE-scale)
Time Frame: baseline, 12 months follow-up
baseline, 12 months follow-up
Somatization (SCL-90-R)
Time Frame: baseline, 12 months follow-up
baseline, 12 months follow-up
Depression
Time Frame: baseline, 12 months follow-up
baseline, 12 months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2003

Study Completion (Actual)

March 1, 2006

Study Registration Dates

First Submitted

September 27, 2005

First Submitted That Met QC Criteria

September 27, 2005

First Posted (Estimate)

September 29, 2005

Study Record Updates

Last Update Posted (Estimate)

October 29, 2007

Last Update Submitted That Met QC Criteria

October 26, 2007

Last Verified

October 1, 2007

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rheumatoid Arthritis

Clinical Trials on Counselling and 3-week medical in-patient rehabilitation

3
Subscribe